13-Valent Pneumococcal Conjugate Vaccine
Target Group: Persons aged from 6 weeks to 5 years
Function: Stimulate the body to produce humoral immune response. Prevent invasive diseases caused by pneumococcal serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F (including bacteremic pneumonia, meningitis, septicemia and bacteremia).